Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab-emtansine induced pleural and pericardial effusions.
Lombardi J, Lory P, Martin N, Mayeur D, Combret S, Grandvuillemin A, Boulay C, Schmitt A. Lombardi J, et al. Among authors: schmitt a. J Oncol Pharm Pract. 2021 Dec;27(8):2041-2044. doi: 10.1177/10781552211015772. Epub 2021 May 18. J Oncol Pharm Pract. 2021. PMID: 34000917
Population Pharmacokinetics of Palbociclib in aReal-World Situation.
Royer B, Kaderbhaï C, Fumet JD, Hennequin A, Desmoulins I, Ladoire S, Ayati S, Mayeur D, Ilie S, Schmitt A. Royer B, et al. Among authors: schmitt a. Pharmaceuticals (Basel). 2021 Feb 24;14(3):181. doi: 10.3390/ph14030181. Pharmaceuticals (Basel). 2021. PMID: 33668400 Free PMC article.
Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.
Thomas F, Maillard M, Launay M, Tron C, Etienne-Grimaldi MC, Gautier-Veyret E, Haufroid V, Pallet N, Royer B, Narjoz C, Schmitt A; Groupe de Pharmacologie Clinique Oncologique (GPCO-UNICANCER). Thomas F, et al. Among authors: schmitt a. Ann Oncol. 2021 Jun;32(6):810-811. doi: 10.1016/j.annonc.2021.02.020. Epub 2021 Mar 1. Ann Oncol. 2021. PMID: 33662499 Free article. No abstract available.
Pharmacokinetics and Pharmacodynamic of Alpelisib.
Royer B, Kaderbhaï CG, Schmitt A. Royer B, et al. Among authors: schmitt a. Clin Pharmacokinet. 2023 Jan;62(1):45-53. doi: 10.1007/s40262-022-01195-2. Epub 2023 Jan 12. Clin Pharmacokinet. 2023. PMID: 36633813 Review.
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Reda M, Macaire P, Bellio H, Uwer L, Ilie S, Lorgis V, Hennequin A, Ladoire S, Rederstorff E, Fumoleau P, Isambert N, Bonnin N, You B, Freyer G, Desmoulins I, Schmitt A. Reda M, et al. Among authors: schmitt a. Cancer Chemother Pharmacol. 2022 Feb;89(2):197-208. doi: 10.1007/s00280-021-04395-y. Epub 2022 Jan 8. Cancer Chemother Pharmacol. 2022. PMID: 34997290
1,880 results